The Lupus Research Alliance (LRA), the largest private funder of lupus research worldwide, today announced that a total of 33 studies, funded by the organization or supported by its clinical research affiliate Lupus Therapeutics, will be presented at ACR Convergence 2024.
Formycon AG publishes preliminary figures for the 2023 financial year and guidance for the 2024 financial year – Biotech Investments
Formycon AG / Key word(s): Preliminary Results/Forecast Formycon AG publishes preliminary figures for the 2023 financial year and guidance for the 2024 financial year 12-Apr-2024